Atos - Pharmaceuticals / Life Sciences Operational Transformation

Atos - Pharmaceuticals / Life Sciences Operational Transformation

Who is This Vendor Assessment For?
NelsonHall’s pharmaceuticals / life sciences operational transformation profile on Atos is a comprehensive assessment of Atos’s offerings and capabilities, designed for:
• Sourcing managers monitoring the capabilities of existing suppliers of pharmaceuticals / life sciences operational transformation services and identifying vendor suitability for operational transformation services RFPs
• Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
• Financial analysts and investors specializing in the pharmaceuticals / life sciences services sector.

Key Findings & Highlights
Atos positions itself as a digital operations company and approaches pharmaceutical/life sciences operational transformation by simplifying and reimagining business processes and operations through technology, infrastructure, analytics, and business process services.
Atos has a dedicated healthcare and life science practice, which has been expanding from Europe to North America. In 2017, Atos acquired Pursuit Healthcare Advisors, Conduent's healthcare provider consulting business, and Conduent's Breakaway Group business with subject matter experts across payer, provider, and life sciences business to expand its presence in the U.S. digital health market.
Atos's life sciences practice offers end-to-end capabilities, including supercomputing. It has a CoE for the end-to-end value chain of pharmaceutical companies, medical devices, distributors, healthcare payers, and providers. About 20-25% of Atos's total headcount is currently associated with life sciences.
Atos's main areas of competence include:
• Application development and maintenance
• Implementation of SAP, Oracle, and new wave technologies
• Utilizing high-performance computing capabilities to bring in ML, AI, and automation.
 

Scope of the Report
The report provides a comprehensive and objective analysis of Atos’s pharmaceuticals / life sciences operational transformation offerings and capabilities, and market and financial strengths, including:
• Identification of the company’s strategy, emphasis, and new developments
• Analysis of the company’s strengths, weaknesses, and outlook
• Revenue estimates
• Analysis of the profile of the company’s customer base, including the company’s targeting strategy and examples of current contracts
• Analysis of the company’s offerings and key service components
• Analysis of the company’s delivery organization, including the location of delivery locations.